Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mallinckrodt
ClinicalTrials.gov Identifier:
NCT01601236
First received: May 15, 2012
Last updated: November 28, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2016
  Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)